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This paper reports the first analysis of small molecules on the Agilent bio-analyser. The Bioanalyzer is
a commercial lab-on-a-chip instrument designed for the analysis of DNA and proteins. We
demonstrate that the instrument is suitable for analyses beyond its design specifications. Amphetamine,
methamphetamine and pseudoephedrine were separated with a 50 mM borate and 50 mM sodium
dodecyl sulfate (SDS) buffer at pH 9.66. The analytes were derivatised with fluorescein
isothiocyanate (FITC) in 3 minutes with a heating block set at 90 C, reducing the typical time of
12 hours required for amine-labelling. Analytes were detected by LED-induced fluorescence
(lex ¼ 525 nm and lem ¼ 470 nm). Furthermore, five amphetamine analogues were baseline separated
within 1 minute. An average limit of detection of 0.6 mg mL1 and limit of quantification of 2.2 mg mL1
were obtained for all analytes. These rapid analyses in conjunction with a fast and reliable
derivatisation method with FITC demonstrate its potential use for the in-field analysis of samples of
forensic significance.
Introduction
Amphetamines are a group of psycho-stimulants which may
cause anxiety, hallucination, violence and antisocial behaviour.1
The relatively simple methods of manufacture contribute to the
popularity and availability of amphetamines in Asia, North
America and Oceania. Global seizures of amphetamine type
stimulants (ATS) have risen significantly over the last two
decades. Since 1990, a 10-fold increase in amphetamine seizures
has been reported, with over 50 tonnes seized in 2007.2 This
significant increase has generated a need for a fast and highly
automated method for the in-field identification of ATS.
The analysis of clandestine preparations of amphetamines is
usually performed in the laboratory using gas chromatography-
mass spectrometry (GC-MS),3–6 liquid chromatography (LC)7–9
and capillary electrophoresis (CE).10–12 Capillary electrophoresis
has been reported for the analysis of ATS in various matrices
including blood, urine and oral fluids.13–19
In-field, presumptive colour tests and ion mobility
spectroscopy (IMS) are the most commonly employed tech-
niques for the detection of ATS. However, both of these methods
lack sensitivity and frequently result in false positives from
interferences.20,21 Lab-on-a-chip (LOC) devices perform
extremely fast, cost-effective separations and are also portable.22
LOC is an attractive alternative for the rapid analysis of forensic
samples including DNA, explosives and illicit drugs.23–26
Fluorescence is the most common method of choice for
analyte detection in LOC applications. Fluorescein iso-
thiocyanate (FITC) is a common fluorescent labelling reagent for
amines with excellent quantum efficiency and high stability of its
derivatives.27 The reaction of FITC with proteins and amino
acids was first reported in 1969 by Maeda et al.27 and has been
used to label amphetamines and other amine-containing
compounds.28,29 Typical derivatisation times with FITC have
been up to 12 hours, with recent attempts to shorten the reaction
time. Dominguez-Vega et al.30 described an accelerated FITC
derivatisation of the amino acid ornithine. The reaction time was
reduced from 16 hours to 10 minutes by the use of an ultrasonic
probe. Zhou et al.31 reported a microwave-assisted derivatisation
procedure for amino acids with FITC which took approximately
3 minutes. The signal intensity associated with the microwave
procedure was improved in comparison to the procedures at
room temperature and 100 C in a water-bath.31
Ramseier et al.28 reported the separation and detection of
amphetamine analogues in human urine. The separation run
time was 10 minutes, involving a 24 hour labelling process with
FITC. This study utilised a laboratory constructed device and an
argon ion laser with excitation at 488 nm. Alternative
amino-reactive fluorophores such as o-phthaldialdehyde (OPA),
dichlorotrizinylaminofluorescein (DTAF) and nitro benzofur-
azane derivatives have also been used to label amphetamines.32–35
The Bioanalyzer 2100 is a commercial LOC system, fitted with
both LED-Induced Fluorescence (LED-IF) and Laser Induced
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Fluorescence (LIF) detection systems. This device is compact
and portable, with a mass of 10 kg. The Bioanalyzer is robust and
can withstand operating temperatures of between 5 and 40 C.36
This paper demonstrates the separation and detection of
Amphetamine (AMP), Methamphetamine (MA) and
Pseudoephedrine (PSE) and selected analogues with the
Bioanalyzer. The ATS were rapidly derivatised with FITC by
a temperature-accelerated procedure using a dry heating block.
The derivatised ATS and analogues were separated by micellar
electrokinetic chromatography (MEKC) employing a standard
commercial glass microchip.
Experimental
Apparatus
All experiments were performed on an Agilent 2100 Bioanalyzer
using the Agilent 2100 Expert software (Agilent technologies,
Waldbronn, Germany). Detection was by LED-IF (lex 525 nm, lem
470 nm). All separations were performed using standard DNA 500
microchips obtained from Agilent Technologies (Forest Hill, Aus-
tralia). The chips were fabricated from soda lime glass. The micro-
channels which interconnect 12 sample wells have a depth of 10 mm
and width of 50 mm. The separation channel length was 15 mm.
Chemicals
Sodium hydroxide, sodium dodecyl sulfate (SDS), nile blue
chloride, sodium tetraborate and FITC (>90%) were purchased
from Sigma Aldrich (Sydney, Australia). Individual
standards of 2-(4-methoxyphenyl)ethylamine, 2-bromo-N-
methylbenzenemethanamine, 2-methoxy-N-methylaniline,
5-aminomethyl-7-chloro-1,3-benzodioxol-hydrochloride and
2-methoxyphenethylamine were also purchased from Sigma
Aldrich (Sydney, Australia) as concentrated solids or
solutions (in methanol). Pseudoephedrine hydrochloride,
dexamphetamine sulfate and methamphetamine hydrochloride
were obtained from the National Measurement Institute (Syd-
ney, Australia). Table 1 lists the chemical structures of the target
compounds.
Table 1 Structures of the target amphetamines and amphetamine analogues
Name Abbreviation Structure
2-(4-Methoxyphenyl)ethylamine 2-4-MPEA
2-Bromo-N-methylbenzenemethanamine BMBA
2-Methoxy-N-methylaniline 2-MMA
5-Aminomethyl-7-chloro-1,3-benzodioxol-hydrochloride AM-C-BD
2-Methoxyphenethylamine MPEA
Pseudoephedrine PSE
Amphetamine AMP
Methamphetamine MA
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Electrolyte preparation
Electrolytes and sample stock solutions were prepared in ultra--
pure water (Arium 611, Sartorius AG, Goettingen, Germany).
The separation electrolyte consisted of 50mMsodium tetraborate
buffer at a pH of 9.66 with the addition of 50 mM SDS. The
electrolyte was mixed, sonicated for 5 minutes and filtered
through a 0.20 mm syringe filter prior to injection (Milipore,
Billerica,MA,USA). All electrolyte solutions and stock solutions
of amphetamine analogues were kept in the refrigerator at 4 C
and fresh solutions were prepared daily. A concentration of 1 mM
nile blue dyewas diluted in the running buffer and primed through
the microchannels prior to analysis for laser focussing.
Analyte preparation
FITC stock solution. A 10 mM stock solution of FITC was
prepared in analytical reagent grade acetone and stored in
a plastic bottle wrapped in aluminium foil at 18 C.
Amphetamine analogues and ATS standards. Individual stock
solutions of all analogues and ATS standards were prepared via
dilution in ultra-purewater to a final concentration of 1000mgmL1.
Derivatisation of stock solutions was performed with FITC; 100 mL
of analogue was diluted in 100 mL of 10 mM sodium tetraborate
buffer (pH9.66) and labelled for 3minutes at 90 Cafter the addition
of 100 mL of 10 mM FITC. A dry heater block (Ratek-DBH30D—
www.ratek.com.au) was employed. Labelling was carried out in
1.7mLgraduatedmicrotubeswrapped in aluminium foil with the lid
closed. Following derivatisation, the labelled analogues were diluted
to 10 mg mL1 in the running buffer for analysis.
Results and discussion
Labelling with FITC
FITC has been widely used as a derivatisation reagent due to its
excellent quantum efficiency, high molar absorptivity and
stability of products.28,36Experiments were performed to simplify
the FITC derivatisation procedure using a dry heating block.
Initially, experiments were conducted using a water-bath as
performed by Zhou et al.,31 however a dry heating block was
chosen due to its reduced complexity. Whilst the heating block
used is portable (W 283  D 265  H 100 mm, 4.5 kg and 60
samples capacity), a wide range of more compact heating blocks
are also available which would further enhance the portability.
Fig. 1 summarises the influence of temperature on the peak
height for derivatised PSE with a 5 minute reaction time. Error
bars were estimated from the standard deviation for the PSE
fluorescence intensity from triplicate derivatisation of PSE at
each temperature and triplicate injections on a single chip. i.e.
a total of 3 chips were used for each temperature experiment. The
response increased linearly with increasing temperature. As
expected there was also a concomitant decrease in the signal of
FITC. Temperatures beyond 100 C were not investigated as the
reaction mixture boiled. The optimal temperature was chosen as
90 C; a compromise between sensitivity, high PSE and low
FITC fluorescence intensities and reproducibility.
Fig. 2 illustrates the influence of reaction time upon the signal
intensity at the optimum temperature of 90 C. As before, error
bars were calculated from the standard deviations of triplicate
time experiments and triplicate injections on separate chips. The
results show a sharp increase in the signal intensity of PSE upuntil
180 seconds where it reached a plateau. As expected, the FITC
signal intensity gradually decreased over time, again confirming
the consumption of FITC. The optimum time was 180 seconds
determined by maximum PSE signal intensity, minimum FITC
signal intensity and lowest fluorescence signal variability.
The dry heating block procedure was compared against
microwave and temperature assisted derivatisation methods
described by Dominguez-Vega and Zhou et al.30,31 The
separation profile of a 24 hour standard procedure at room
temperature is shown in Fig. 3a. The 3 minute microwave
programme consisted of alternating 30 second periods of
microwave irradiation.
Fig. 1 The influence of temperature on the fluorescence intensity of
derivatised PSE (5 minute reaction time). Error bars represent the
corresponding standard deviations of the peak heights for each
temperature experiment (n ¼ 3), and triplicate injection of derivatised
PSE. Each experiment was performed on a separate chip.
Fig. 2 The influence of time on the fluorescence intensity of derivatised
PSE for a reaction performed at 90 C. Error bars represent the
corresponding standard deviations of the derivatisation time periods for
each temperature experiment (n ¼ 3), and triplicate injection of
derivatised PSE. Each experiment was performed on a separate chip.
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A microwave irradiation power of 250 watts was applied to
a 300 mL mixture contained in a closed 1.7 mL centrifuge vial.
With the application of microwave irradiation for 3 minutes
(Fig. 3b), a similar fluorescence intensity was observed. When the
reaction was performed using a dry heating block set at 90 C,
the fluorescence signal intensity was approximately doubled
(Fig. 3c). The temperature-accelerated method was chosen for
optimisation due to its simplicity and greater suitability for
in-field analysis. A heating block was chosen due to its increased
feasibility for laboratory and in-field analysis.
Electrolyte optimisation
Sodium tetraborate was chosen as a suitable buffer given the
average pKa for the amphetamine analogueswas 8.7.Optimisation
experiments considered electrolyte pH, and the concentration of
borate andSDS.At lower pH, thepeaksbroadened, decreasing the
efficiency of the separation. The separation efficiency increased
with increasing borate and SDS concentration up to a maximum
concentration of 50 mM of each. Therefore the best separation
buffer comprised 50 mM sodium tetraborate and 50 mM SDS at
pH 9.66. The influence of hydroxyethyl-cellulose, methanol and
acetonitrile was also investigated with the objective of improving
the separation by slowing down the electroosmotic flow (EOF).
However, there was no significant enhancement of separation and
the baseline noise increased.
MEKC separation of labelled analogues and ATS
Fig.4 shows the separationoffiveamphetamineanaloguesemploying
50 mM sodium tetraborate and 50 mM SDS. These analogues were
chosendue to theirphysical andchemical similarity toAMPandMA,
as well as to highlight the potential of the Bioanalyzer lab-on-a-chip
device for the analysis of ATS and precursors.
Fig. 5 shows the separation of pseudoephedrine, amphetamine,
and methamphetamine. These compounds were treated separately
to simulate a typical clandestine laboratory analysis such as the
rapid identification of the presence of amphetamine or
methamphetamine and its potential synthesis route, i.e. the manu-
facture of methamphetamine from pseudoephedrine as a starting
material. In both cases all compounds were resolved in less than 1
minute, with sufficient resolution for identification. The method
was evaluated in terms of sensitivity and linearity for all
amphetamine analogues. These results are summarised in Table 2.
The limit of detection (LOD) and limit of quantification
(LOQ) were calculated for each compound (n ¼ 6) based on
3 times and 10 times the signal-to-noise ratio, respectively.
Average LOD and LOQ values were 0.6 mg mL1 and
2.2 mg mL1, respectively. This is consistent with detection limits
of 0.5 mg mL1 for 3,4-methylenedioxy methamphetamine
(MDMA) for a CE-LIF method reported by Fang et al.26
The linearity of each analyte was determined in the concen-
tration range of 1 to 50 mg mL1 (n ¼ 6), producing correlation
co-efficients (R2) that ranged from 0.960 to 0.995.
Fig. 4 Electropherogram of 5 amphetamine analogues (30 mg mL1)
using LED-IF (lem 470, lem 525). Conditions: 50 mM SDS + 50 mM
sodium tetraborate, pH 9.66; 25 C; injection time 2 seconds; injection
voltage 1.5 kV; separation voltage 1.5 kV; (1) 2-4-MPEA, (2) BMBA, (3)
2-MMA, (4) AM-C-BD and (5) MPEA.
Fig. 5 Electropherogram showing the optimised separation of 3 ATS
standards (30 mg mL1) using LED-IF (lem 470, lem 525). Conditions:
50 mM SDS + 50 mM sodium tetraborate, pH 9.66; 25 C; injection time
2 seconds; injection voltage 1.5 kV; separation voltage 1.5 kV; (1) PSE,
(2) AMP and (3) MA.
Fig. 3 Separation profiles of the fluorescence intensity for amphetamine
analogues (20 mg mL1): (a) 24 hours at room temperature, (b) 3 minute
microwave program—30 second periods alternating between microwave
application and resting, (c) 3 minutes at 90 C. Separation conditions as
in Fig. 4. (1) 2-4-MPEA, (2) BMBA, (3) 2-MMA, (4) AM-C-BD and (5)
MPEA.
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The repeatability of the migration times was evaluated for each
analogue (30 mg mL1) from repeat injections both within-chip
(n ¼ 6) and between-chip (n ¼ 12). The corresponding relative
standard deviations (RSDs) for all analytes ranged from 1.8 to
4.4 and 2.7 to 4.9, respectively (Table 3).
Conclusions
A fast and reliablemethod for the derivatisation of amphetamine-
type stimulants with FITC and subsequent analysis via LED-IF
using a portable lab-on-a-chip device was demonstrated.
The rapid derivatisation reduced the typical 12 hours
derivatisation of the analytes to 3 minutes. The procedure
employed a portable dry heating block, set at 90 C for the
labelling of amphetamines.
The separation of AMP, MA and PSE was complete within
1 minute. Limits of detection and limits of quantification
were similar to reported CE-LIF methods ranging from 0.4 to
0.9 mg mL1 and 1.5 to 3.0 mg mL1, respectively.
The derivatisation procedure with FITC was robust and
reliable and was suitable for the in-field detection of
amphetamines and other ATS.
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Table 2 Analytical performance data for amphetamine analogues and
ATS
Analyte
Sensitivity limits
(n ¼ 6, mg mL1)
Calibration R2
(n ¼ 6, 1–50 mg mL1)LODa LOQa
2-4-MPEA 0.6 2.0 0.988
BMBA 0.7 2.3 0.991
2-MMA 0.7 2.3 0.989
AM-C-BD 0.9 3.0 0.983
MPEA 0.8 2.8 0.965
PSE 0.5 1.8 0.995
AMP 0.4 1.5 0.990
MA 0.4 1.5 0.960
a LOD and LOQ calculations were determined using 3 times and 10 times
the signal-to-noise ratio, respectively (n ¼ 6).
Table 3 Separation and detection reproducibility for amphetamine
analogues and ATS
Analyte
Average migration time
 standard deviationa/s
Adjusted migration times %
RSDa
Within-chip Between-chip
2-4-MPEA 26  0.5 1.9 2.8
BMBA 34.9  0.6 1.8 2.7
2-MMA 37.7  0.8 2.1 3.5
AM-C-BD 47.6  2.1 4.4 4.9
MPEA 50.5  1.9 3.7 4.7
PSE 55.3  2.3 2.3 4.1
AMP 58.4  2.1 2.1 3.6
MA 67.2  3.2 2.5 4.8
a Calculated from repeated injections of a 30 mg mL1 standard mixture.
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